August 21, 2025 6:35 pm

Japanese Encephalitis Vaccination Expansion in Tamil Nadu

CURRENT AFFAIRS: Japanese Encephalitis, Tamil Nadu Health Department, JE vaccination programme, mosquito borne disease, vaccination drive, children immunization, CNS infection, public health campaign, endemic districts, viral disease

Japanese Encephalitis Vaccination Expansion in Tamil Nadu

Expansion of the JE Programme

Japanese Encephalitis Vaccination Expansion in Tamil Nadu: The Tamil Nadu Health Department has expanded the Japanese Encephalitis (JE) vaccination programme to 7 new districts. This marks a significant step in strengthening disease prevention measures across the state. A total of 27,63,152 children aged 1 to 15 years will be covered with a single dose of JE vaccine.

Target Districts and Coverage

The additional districts included are Chennai (excluding two already covered zones), Chengalpattu, Tirunelveli, Tenkasi, Kancheepuram, Nagapattinam, and Vellore. These areas have reported cases in recent years, prompting the health department to extend vaccination coverage.

Static GK fact: The first case of Japanese Encephalitis in India was reported in Vellore, Tamil Nadu in 1955.

Implementation in Institutions

The campaign will be conducted across government schools, government-aided schools, anganwadi centres, orphanages, and juvenile homes. This approach ensures maximum coverage of vulnerable children within the 1–15 age group.

Static GK fact: Anganwadi centres were introduced in 1975 under the Integrated Child Development Services (ICDS) scheme to provide health and nutrition services to children.

Disease Burden and Risks

Japanese Encephalitis is a mosquito-borne zoonotic viral disease that primarily affects the central nervous system (CNS). Severe cases may lead to complications such as seizures, long-term neurological disability, or death. With no specific treatment available, vaccination remains the most effective preventive measure.

Static GK Tip: The Culex mosquito is the primary vector of Japanese Encephalitis in India.

Historical Implementation in Tamil Nadu

The JE vaccination programme was first launched in 2007, initially covering 15 endemic revenue districts. Over the years, the state has consistently scaled up its efforts in response to outbreak patterns and epidemiological data.

Static GK fact: The JE vaccine used in India is the SA 14-14-2, a live attenuated vaccine originally developed in China.

National and Global Perspective

India contributes to a large share of JE cases reported worldwide, mostly from the eastern and southern states. Regular vaccination campaigns have significantly reduced disease incidence in states like Uttar Pradesh, Assam, Bihar, and Tamil Nadu.

Static GK fact: Japanese Encephalitis was first recognized in Japan in 1871, and the first vaccine was introduced in 1941.

Conclusion

The expansion of JE vaccination in Tamil Nadu is a proactive step toward reducing the burden of this potentially fatal disease. Covering nearly 28 lakh children across seven additional districts will help in strengthening herd immunity and preventing future outbreaks.

Static Usthadian Current Affairs Table

Japanese Encephalitis Vaccination Expansion in Tamil Nadu:

Topic Detail
Disease Japanese Encephalitis (JE)
Nature Mosquito-borne viral zoonotic disease
Affected System Central Nervous System (CNS)
Transmission Vector Culex mosquito
Age Group Covered 1–15 years
No. of Children 27,63,152
Newly Added Districts Chennai, Chengalpattu, Tirunelveli, Tenkasi, Kancheepuram, Nagapattinam, Vellore
Existing Coverage 15 endemic districts since 2007
Vaccine Used SA 14-14-2 live attenuated vaccine
Implementation Venues Government schools, aided schools, anganwadis, orphanages, juvenile homes
Japanese Encephalitis Vaccination Expansion in Tamil Nadu
  1. Tamil Nadu expanded JE vaccination to 7 new districts.
  2. Programme covers 63 lakh children (1–15 years).
  3. Districts added: Chennai, Chengalpattu, Tirunelveli, Tenkasi, Kancheepuram, Nagapattinam, Vellore.
  4. First JE case in India reported in Vellore, 1955.
  5. Campaign held in schools, anganwadis, orphanages, juvenile homes.
  6. Anganwadi centres launched in 1975 under ICDS scheme.
  7. JE is a mosquito-borne viral disease.
  8. Affects the Central Nervous System (CNS).
  9. Severe cases can cause seizures or death.
  10. No specific treatment, only vaccination is effective.
  11. Main vector: Culex mosquito.
  12. JE vaccine SA 14-14-2 developed in China.
  13. TN launched JE programme in 2007 for 15 endemic districts.
  14. India among the largest contributors of JE cases globally.
  15. Regular vaccination reduced cases in UP, Assam, Bihar, TN.
  16. JE first identified in Japan in 1871.
  17. First vaccine introduced in 1941.
  18. Expansion strengthens herd immunity.
  19. Helps prevent future outbreaks in Tamil Nadu.
  20. Reflects TN’s proactive public health approach.

Q1. How many children will be covered under the new JE vaccination expansion in Tamil Nadu?


Q2. In which year was the JE vaccination programme first launched in Tamil Nadu?


Q3. Which mosquito is the primary vector for Japanese Encephalitis in India?


Q4. Where was the first case of JE in India reported?


Q5. Which vaccine is used in India for JE immunization?


Your Score: 0

Current Affairs PDF August 21

Descriptive CA PDF

One-Liner CA PDF

MCQ CA PDF​

CA PDF Tamil

Descriptive CA PDF Tamil

One-Liner CA PDF Tamil

MCQ CA PDF Tamil

CA PDF Hindi

Descriptive CA PDF Hindi

One-Liner CA PDF Hindi

MCQ CA PDF Hindi

News of the Day

Premium

National Tribal Health Conclave 2025: Advancing Inclusive Healthcare for Tribal India
New Client Special Offer

20% Off

Aenean leo ligulaconsequat vitae, eleifend acer neque sed ipsum. Nam quam nunc, blandit vel, tempus.